ARIX logo

Arix Bioscience plc Stock Price

LSE:ARIX Community·UK£176.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ARIX Share Price Performance

UK£0
0.00 (0.00%)
UK£0
0.00 (0.00%)
Price UK£0

ARIX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

1 Risk
2 Rewards

Arix Bioscience plc Key Details

UK£14.2m

Revenue

UK£0

Cost of Revenue

UK£14.2m

Gross Profit

-UK£799.0k

Other Expenses

UK£15.0m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
0.12
100.00%
105.64%
0%
View Full Analysis

About ARIX

Founded
2015
Employees
9
CEO
n/a
WebsiteView website
arixbioscience.com

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.

Recent ARIX News & Updates

Recent updates

No updates